Suicide study: STAT-PC vs YST-III
Official title Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
ClinicalTrials.gov ID: NCT05869552
What this study is testing
- What it's testing
- This study is testing whether two short online talks can help prevent suicide. It looks at how well these talks work for young adults.
- Who it's for
- You may be able to join if you are 18 to 24 and identify as sexual or gender diverse.
- What's involved
- You would get one of two short online talks. These talks are designed to help prevent suicide.
- Time commitment
- The study involves getting one of the two short online talks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 24
You may be able to join if
- be aged 18-24 at the time of enrollment
- not have received mental health services in the past 90 days, excluding medication and case management
- English-speaking
- screen positive for suicide risk
You likely can't join if
- are actively suicidal
- have a developmental disability that would preclude them from participating in the study intervention
- who are impaired due to psychosis, mania, or substance use that would prevent them from providing consent.
- Participants will also be excluded at YST-III sites if they are unable to identify a minimum of one support person to participate in the intervention...
The study team makes the final eligibility decision.
Where it is enrolling
- Pittsburgh, Pennsylvania, United States
- Austin, Texas, United States
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 24 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Pittsburgh, Pennsylvania, United States; Austin, Texas, United States; Dallas, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.